Showing results (1401-1410 of 99,640) with videos related to
Sort By:
Pageof 9,964
Journal of Bacteriology|December 5, 2012
Draft genome sequence of the flocculating Zymomonas mobilis strain ZM401 (ATCC 31822)Ning Zhao, Yun Bai, Xin-Qing Zhao, et al.Molecular and Cellular Biochemistry|October 8, 2024
Carbon monoxide-releasing molecule-3 ameliorates traumatic brain injury-induced cardiac dysfunctions via inhibition of pyroptosis and apoptosisJing Bai, Wen-Bo Sun, Wei-Chao Zheng, et al.Advanced Healthcare Materials|July 13, 2017
Promoting Cell Migration in Tissue Engineering Scaffolds with Graded ChannelsDegang Yang, Zhitong Zhao, Fan Bai, et al.Journal of Inflammation Research|August 16, 2021
Gut Microbiota-Derived Inflammation-Related Serum Metabolites as Potential Biomarkers for Major Depressive DisorderShunjie Bai, Jing Xie, Huili Bai, et al.Biotechnology Advances|May 13, 2022
Recent advances in high-throughput metabolic engineering: Generation of oligonucleotide-mediated genetic librariesYe Li, Emmanuel Osei Mensah, Eric Fordjour, et al.Journal of Proteome Research|August 18, 2020
Transcriptomic and Proteomic Analysis Revealed the Effect of <i>Funneliformis mosseae</i> in Soybean Roots Differential Expression Genes and ProteinsXue-Qi Zhang, Li Bai, Hai-Bing Sun, et al.Shock (Augusta, Ga.)|October 26, 2020
Carbon Monoxide-Releasing Molecule-3 Ameliorates Acute Lung Injury in a Model of Hemorrhagic Shock and Resuscitation: Roles of p38MAPK Signaling PathwayJing Bai, Yang Bai, Xu-Peng Wang, et al.Frontiers in Microbiology|June 10, 2022
c-di-AMP Accumulation Regulates Growth, Metabolism, and Immunogenicity of <i>Mycobacterium smegmatis</i>Huanhuan Ning, Xuan Liang, Yanling Xie, et al.Journal of Hazardous Materials|July 27, 2024
Screening of optimal cleaning methods to reduce microplastic residues on strawberry surfaces: Characterization of microplastics in strawberry wash waterYeran Bai, Yanhua Chen, Yang Song, et al.Frontiers in Oncology|July 30, 2021
Clinical Activity and Safety of Penpulimab (Anti-PD-1) With Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial (AK105-203)Chun Han, Sisi Ye, Chunhong Hu, et al.Pageof 9,964